{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T15:18:11Z","timestamp":1789312691726,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are among the leading cause of morbidity and mortality in low-and-middle-income countries (LMICs) but evidence in these contexts regarding the effectiveness of primary prevention interventions taking into account patient adherence is scarce. We aimed to evaluate the effectiveness of a cardiovascular risk management program (De Todo Coraz\u00f3n - DTC program) in the incidence of the first cardiovascular outcome (CVO) in a low-income population from the Caribbean region of Colombia using adherence as the main variable of exposure.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective propensity score-matched cohort study was conducted. Adult patients with a diagnosis of hypertension (HTA), diabetes mellitus (DM), chronic kidney disease (CKD), or dyslipidemia affiliated to the DTC program between 2013 and 2018 were considered as the study population. Patients with 30 to 76\u2009years, without a history of CVOs, and with more than 6 months of exposure to the program were included. The main outcome of interest was the reduction in the risk of CVOs (stroke, myocardial infarction, or congestive heart failure) based on the adherence to the intervention (attendance to medical appointments with health care professionals and the control of cardiovascular risk factors). Kaplan Meier curves and propensity score-matched Cox regression models were used to evaluate the association between adherence and the incidence of CVOs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 52,507 patients were included. After propensity score matching, a sample of 35,574 patients was analyzed. Mean (SD) exposure time was 1.97 (0.92) years. Being adherent to the program was associated to a 85.4, 71.9, 32.4 and 78.9% risk reduction of in the low (HR 0.14; 95% CI 0.05\u20130.37; <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), medium (HR 0.28; 95% CI 0.21\u20130.36; <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), high-risk with DM (HR 0.67; 95% CI 0.43\u20131.04; <jats:italic>p<\/jats:italic>\u00a0=\u20090.075) and hig-risk without DM (HR 0.21; 95% CI 0.09\u20130.48; p\u2009&lt;\u20090.001) categories, respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The DTC program is effective in the reduction of the risk of CVOs. Population-based interventions may be an important strategy for the prevention of CVOs in underserved populations in the context of LMICs. A more exhaustive emphasis on the control of diabetes mellitus should be considered in these strategies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09516-5","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:15:30Z","timestamp":1600355730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a low-income population from Colombia: a real-world\u00a0propensity score-matched cohort study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6790-7112","authenticated-orcid":false,"given":"Pablo","family":"Miranda-Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salcedo-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devian","family":"Parra-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusvelt","family":"Vargas-Moranth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson Rafael","family":"Alvis-Zakzuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo","family":"Paz-Wilches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fern\u00e1ndez-Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"De la-Hoz Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Alvis-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"9516_CR1","volume-title":"Cardiovascular diseases (CVDs) - key facts [internet]. Cardiovascular diseases","author":"World Health Organization - WHO","year":"2017","unstructured":"World Health Organization - WHO. Cardiovascular diseases (CVDs) - key facts [internet]. Cardiovascular diseases; 2017. [cited 2019 Oct 15]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"9516_CR2","doi-asserted-by":"publisher","unstructured":"Miranda-Machado P, Salcedo-Mej\u00eda F, Wilches JP, Fernandez-Mercado J, De La Hoz-Restrepo F, Alvis-Guzm\u00e1n N. First cardiovascular event in patients with type 2 diabetes mellitus of a cardiovascular risk management program of a poor Colombian population: a cohort study. BMC Cardiovasc Disord. 2019;19(1) [cited 2019 Jan 23]. Available from: https:\/\/doi.org\/10.1186\/s12872-018-0993-z.","DOI":"10.1186\/s12872-018-0993-z"},{"issue":"8","key":"9516_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S2213-8587(14)70040-3","volume":"2","author":"RR Huxley","year":"2014","unstructured":"Huxley RR, Perkovic V. The modifiable burden of worldwide mortality from cardiovascular diseases. Lancet Diabetes Endocrinol. 2014;2(8):604\u20136Available from:. https:\/\/doi.org\/10.1016\/S2213-8587(14)70040-3.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9516_CR4","unstructured":"WHO. Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk [internet]: World Health Organization; 2007. [cited 2020 Jan 22]. Available from: www.inis.ie."},{"key":"9516_CR5","doi-asserted-by":"crossref","unstructured":"Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2011;(1):CD001561.","DOI":"10.1002\/14651858.CD001561.pub3"},{"issue":"8","key":"9516_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCULATIONAHA.115.008721","volume":"133","author":"JD Schwalm","year":"2016","unstructured":"Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource effective strategies to prevent and treat cardiovascular disease. Circulation. 2016;133(8):742\u201355.","journal-title":"Circulation."},{"issue":"3","key":"9516_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/bmjgh-2016-000105","volume":"1","author":"M Owolabi","year":"2016","unstructured":"Owolabi M, Miranda JJ, Yaria J, Ovbiagele B. Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism. BMJ Glob Health. 2016;1(3):105 [cited 2020 Jan 22]. Available from: http:\/\/gh.bmj.com\/.","journal-title":"BMJ Glob Health"},{"issue":"6","key":"9516_CR8","doi-asserted-by":"publisher","first-page":"e748","DOI":"10.1016\/S2214-109X(19)30045-2","volume":"7","author":"A Rosengren","year":"2019","unstructured":"Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the prospective urban rural epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):e748\u201360 [cited 2020 Jan 22]. Available from: www.thelancet.com\/lancetgh.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"9516_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/HCR.0b013e318235c729","volume":"32","author":"NH Miller","year":"2012","unstructured":"Miller NH. Adherence behavior in the prevention and treatment of cardiovascular disease. J Cardiopulm Rehabil Prev. 2012;32(2):63\u201370.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"3","key":"9516_CR10","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/S2214-109X(18)30031-7","volume":"6","author":"A Murphy","year":"2018","unstructured":"Murphy A, Palafox B, Donnell OO, Stuckler D, Perel P, Alhabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status : evidence from the PURE observational study. Lancet Glob Heal. 2018;6(3):e292\u2013301Available from:. https:\/\/doi.org\/10.1016\/S2214-109X(18)30031-7.","journal-title":"Lancet Glob Heal"},{"key":"9516_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1365-3156.2008.02116.x","volume":"13","author":"JJ Miranda","year":"2008","unstructured":"Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13:1225\u201334.","journal-title":"Trop Med Int Health"},{"key":"9516_CR12","volume-title":"Vital statistics: birth and deaths forecasting","author":"Departamento Administrativo Nacional de Estad\u00edstica (DANE)","year":"2018","unstructured":"Departamento Administrativo Nacional de Estad\u00edstica (DANE). Vital statistics: birth and deaths forecasting; 2018."},{"key":"9516_CR13","volume-title":"Country statistics and global health estimates","author":"WHO and UN partners","year":"2015","unstructured":"WHO and UN partners. Country statistics and global health estimates. Colombia: WHO statistical profile; 2015."},{"key":"9516_CR14","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335\u2013806.","DOI":"10.1136\/bmj.39335.541782.AD"},{"issue":"1","key":"9516_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","volume":"75","author":"SR Cole","year":"2004","unstructured":"Cole SR, Hern\u00e1n MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75(1):45\u20139.","journal-title":"Comput Methods Programs Biomed"},{"issue":"7","key":"9516_CR16","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33(7):1242\u201358.","journal-title":"Stat Med"},{"issue":"20","key":"9516_CR17","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/sim.2174","volume":"24","author":"J Xie","year":"2005","unstructured":"Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24(20):3089\u2013110.","journal-title":"Stat Med"},{"key":"9516_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011163.pub2","volume-title":"Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. In: Uthman OA, editor. Cochrane database of systematic reviews","author":"OA Uthman","year":"2015","unstructured":"Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. In: Uthman OA, editor. Cochrane database of systematic reviews. Chichester: Wiley; 2015."},{"issue":"2","key":"9516_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cjca.2015.05.015","volume":"32","author":"S Deb","year":"2016","unstructured":"Deb S, Austin PC, Tu JV, Ko DT, Mazer CD, Kiss A, et al. A review of propensity-score methods and their use in cardiovascular research. Can J Cardiol. 2016;32(2):259\u201365. https:\/\/doi.org\/10.1016\/j.cjca.2015.05.015.","journal-title":"Can J Cardiol"},{"key":"9516_CR20","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Resoluci\u00f3n N\u00famero 8430 de 1993 [Internet]. Available from: https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/RESOLUCION-8430-DE-1993.PDF."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09516-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-09516-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09516-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T23:17:33Z","timestamp":1631834253000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09516-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9516"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09516-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"15 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Access to the anonymized patient-level data and the approval of the study protocol was granted by the Research Committee of Mutual Ser in June of 2018. Informed consent was obtained from all individuals included. As this study does not represent a risk to the included participants, no ethical approval was required according to the Resolution 8430 of 1993 of the Ministry of Health of Colombia [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1416"}}